Capilla J, Clemons K, Stevens D
Med Mycol. 2007; 45(8):657-84.
PMID: 18027253
PMC: 7107685.
DOI: 10.1080/13693780701644140.
Ciccocioppo R, DAlo S, di Sabatino A, Parroni R, Rossi M, Doglioni C
Clin Exp Immunol. 2002; 128(1):88-93.
PMID: 11982595
PMC: 1906355.
DOI: 10.1046/j.1365-2249.2002.01795.x.
Pouliot N, Maghni K, Sirois P, Rola-Pleszczynski M
Inflammation. 1996; 20(3):263-80.
PMID: 8796380
DOI: 10.1007/BF01488203.
Uchida A, COLOT M, Micksche M
Br J Cancer. 1984; 49(1):17-23.
PMID: 6691897
PMC: 1976666.
DOI: 10.1038/bjc.1984.4.
Albright J, Albright J
Proc Natl Acad Sci U S A. 1983; 80(20):6371-5.
PMID: 6604919
PMC: 394299.
DOI: 10.1073/pnas.80.20.6371.
Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells.
Grimm E, Ramsey K, Mazumder A, Wilson D, Djeu J, Rosenberg S
J Exp Med. 1983; 157(3):884-97.
PMID: 6601174
PMC: 2186968.
DOI: 10.1084/jem.157.3.884.
Natural cytotoxicity of lymphocytes from lymph nodes draining breast carcinoma and its augmentation by interferon and OK432.
Yanagawa E, Uchida A, Micksche M
Cancer Immunol Immunother. 1984; 17(1):1-6.
PMID: 6563940
PMC: 11039075.
DOI: 10.1007/BF00205490.
Large agranular lymphocytes: early non-specific effector cells in allograft rejection in the mouse.
Gregory C, Atkinson M
Immunology. 1984; 53(2):257-65.
PMID: 6386672
PMC: 1454836.
Intrapleural administration of OK432 in cancer patients: augmentation of autologous tumor killing activity of tumor-associated large granular lymphocytes.
Uchida A, Micksche M, Hoshino T
Cancer Immunol Immunother. 1984; 18(1):5-12.
PMID: 6333269
PMC: 11039175.
DOI: 10.1007/BF00205392.
In vitro modulation of human natural killer cell activity by interferon: generation of adherent suppressor cells.
Uchida A, Yanagawa E, Kokoschka E, Micksche M, Koren H
Br J Cancer. 1984; 50(4):483-92.
PMID: 6237664
PMC: 1976901.
DOI: 10.1038/bjc.1984.205.
Target-effector interactions in the rat NK cell system. II. Effects of interferon on lytic efficiency and on pre-NK cells in various organs, rat strains and during ontogeny.
Flexman J, Shellam G
Clin Exp Immunol. 1984; 55(1):229-38.
PMID: 6198116
PMC: 1535778.
A model of the role of natural killer cells in immune surveillance--II.
MERRILL S
J Math Biol. 1983; 17(2):153-62.
PMID: 6193212
DOI: 10.1007/BF00305756.
Recruitment of OKM1 staining lymphocytes with selective binding to K-562 tumour targets by interferon.
Salata R, Schacter B, Ellner J
Clin Exp Immunol. 1983; 52(1):185-90.
PMID: 6190593
PMC: 1535559.
Surface markers and cytotoxic activity of blood natural killer cells studied at the single cell level in Hodgkin's disease.
Jezewska E, Bjorkholm M, Giscombe R, Holm G, Tullgren O
Clin Exp Immunol. 1985; 61(1):96-102.
PMID: 4042422
PMC: 1577250.
Modulation of natural killer activity by thymosin alpha 1 and interferon.
Favalli C, Jezzi T, Mastino A, Riccardi C, Garaci E
Cancer Immunol Immunother. 1985; 20(3):189-92.
PMID: 3851698
PMC: 11038431.
DOI: 10.1007/BF00205574.
Phenotypic and functional characterization of lymphocytes that bind human microvascular endothelial cells in vitro. Evidence for preferential binding of natural killer cells.
Bender J, Pardi R, KARASEK M, Engleman E
J Clin Invest. 1987; 79(6):1679-88.
PMID: 3495552
PMC: 424501.
DOI: 10.1172/JCI113007.
Recombinant interferon alpha 2 stimulation of target-binding by natural killer cells.
Heidemann E, Weber J, Schmidt H, Reichmann U
Klin Wochenschr. 1986; 64(20):1036-40.
PMID: 3465970
DOI: 10.1007/BF01757211.
Interferon-alpha induction of lymphocytes containing parallel tubular structures.
Hoogeveen Y, Smit J, Blom N, van Luyn M, Halie R
Blut. 1988; 56(2):55-61.
PMID: 3342290
DOI: 10.1007/BF00633462.
Application of a new method for detecting the phenotype of target binding cells.
Lindemann R, Jenkins J, Figlin R, Golub S
Cancer Immunol Immunother. 1987; 25(2):153-5.
PMID: 3311361
PMC: 11038544.
DOI: 10.1007/BF00199957.
A model for the differentiation of human natural killer cells. Studies on the in vitro activation of Leu-11+ granular lymphocytes with a natural killer-sensitive tumor cell, K562.
Phillips J, Lanier L
J Exp Med. 1985; 161(6):1464-82.
PMID: 3159818
PMC: 2187621.
DOI: 10.1084/jem.161.6.1464.
